Announcement on Convening the 2024 Annual Performance Briefing

Earlier from Hangzhou Tianmushan Pharmaceutical Enterprise

• Announcement on Reply to Letter from Shanghai Stock Exchange on Information SupervisionMay 17, 2025
• Announcement on Resolution of the 2nd Extraordinary General Meeting in 2025Apr 29, 2025
• Report for Q1 2025Apr 28, 2025
• Announcement on Progress in Application for the Removal of Other Risk Warnings for Corporate StocksApr 23, 2025
• Announcement on Resolution of the 2024 Annual General MeetingApr 22, 2025

Later from Hangzhou Tianmushan Pharmaceutical Enterprise

• Announcement on Outline of the 2024 Annual Performance BriefingJun 6, 2025
• Announcement on Expected Increase in Semi-annual Performance for 2025Jul 15, 2025
• Announcement on Obtaining Notice of Approval for Re-Registration of Drug by the SubsidiaryJul 24, 2025
• 2025 Semi-annual ReportAug 28, 2025
• Announcement on Resolutions of the 15th Meeting of the 12th Board of DirectorsSep 3, 2025